134 related articles for article (PubMed ID: 9785589)
1. Chromosomal losses and gains in meningiomas: comparative genomic hybridization (CGH) study of the whole genome.
Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Hayakawa T
Neurol Res; 1998 Oct; 20(7):612-6. PubMed ID: 9785589
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoglu H; Atasoy MA; Başaran N; Tel E
Neurol Med Chir (Tokyo); 2003 Jan; 43(1):12-8; discussion 19. PubMed ID: 12568317
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.
Ozaki S; Nishizaki T; Ito H; Sasaki K
J Neurooncol; 1999 Jan; 41(2):167-74. PubMed ID: 10222437
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
Weber RG; Boström J; Wolter M; Baudis M; Collins VP; Reifenberger G; Lichter P
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14719-24. PubMed ID: 9405679
[TBL] [Abstract][Full Text] [Related]
6. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal and genetic abnormalities in benign and malignant meningiomas using DNA microarray.
Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
Neurol Res; 2005 Oct; 27(7):747-54. PubMed ID: 16197812
[TBL] [Abstract][Full Text] [Related]
9. Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region.
Korshunov A; Cherekaev V; Bekyashev A; Sycheva R
J Neurooncol; 2007 Jan; 81(2):131-7. PubMed ID: 16850103
[TBL] [Abstract][Full Text] [Related]
10. Novel chromosomal aberrations in a recurrent malignant meningioma.
Pelz AF; Klawunde P; Skalej M; Wieacker P; Kirches E; Schneider T; Mawrin C
Cancer Genet Cytogenet; 2007 Apr; 174(1):48-53. PubMed ID: 17350466
[TBL] [Abstract][Full Text] [Related]
11. Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature.
Ahrendsen JT; Hsu N; Wolf Z; Bryke C; Varma H
J Neuropathol Exp Neurol; 2020 Jun; 79(6):618-625. PubMed ID: 32357369
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal and genetic aberrations differ with meningioma subtype.
Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2004; 21(3):127-33. PubMed ID: 15696974
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
[TBL] [Abstract][Full Text] [Related]
15. Detection of gains and losses in 18 meningiomas by comparative genomic hybridization.
Khan J; Parsa NZ; Harada T; Meltzer PS; Carter NP
Cancer Genet Cytogenet; 1998 Jun; 103(2):95-100. PubMed ID: 9614906
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
[TBL] [Abstract][Full Text] [Related]
17. Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.
Pfisterer WK; Coons SW; Aboul-Enein F; Hendricks WP; Scheck AC; Preul MC
J Neurooncol; 2008 Mar; 87(1):43-50. PubMed ID: 18060363
[TBL] [Abstract][Full Text] [Related]
18. [Cytogenetic aberrations in histologically benign infiltratively growing sphenoid wing meningiomas].
Korshunov AG; Cherekaev VA; Bekiashev AKh; Sycheva RV
Zh Vopr Neirokhir Im N N Burdenko; 2007; (4):11-5. PubMed ID: 18274131
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas.
Lekanne Deprez RH; Riegman PH; van Drunen E; Warringa UL; Groen NA; Stefanko SZ; Koper JW; Avezaat CJ; Mulder PG; Zwarthoff EC
J Neuropathol Exp Neurol; 1995 Mar; 54(2):224-35. PubMed ID: 7876890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
